Vamstar is building the agentic AI platform for commercial operations in Pharma and MedTech. As healthcare buying becomes more complex, suppliers must make faster, better-informed commercial decisions in every market they sell into. Vamstar's platform, Polaris, gives them the intelligence and the AI agents to do it. Polaris combines healthcare commercial data from 100+ countries with AI agents that work alongside commercial, pricing, tender, and market access teams. It covers the commercial cycle from pipeline to market: finding and qualifying opportunities, matching them to the product portfolio, drafting bid responses, setting prices using competitor and award intelligence, and guiding market access strategy. Vamstar deploys Polaris through forward-deployed engineers who embed with customer teams, connect the platform to their systems, and build agents around how each organization works. Its data foundation is strengthened by continuing R&D, including Sovereign-AI funded work on a knowledge graph that links molecules and products, indications, and competitors to commercial outcomes. Founded in 2019 through Antler by Praful Mehta (CEO) and Richard Freeman (CTO), Vamstar is based in the UK with offices in the US, UAE, and India. Five of the world's ten largest MedTech companies, alongside top-10 Pharma manufacturers, use Vamstar to run more efficient commercial operations, raise win rates, and protect margins.